NEVPF
Price:
$0.028
Market Cap:
$715.67M
Abliva AB (publ) is a pharmaceutical firm focused on developing novel treatments for primary mitochondrial disorders. Its product pipeline features KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions. Another compound, NV354, is undergoing preparations for clinical studies, specifically targeting primary mitochondrial diseases linked to Complex I deficiency. Beyond mitochondrial diseases, the company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for traumatic brain injury. Abliva collaborates with a range of institutions and companies, including Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Phil...[Read more]
Industry
Biotechnology
IPO Date
2014-03-20
Stock Exchange
OTC
Ticker
NEVPF
According to Abliva AB (publ)’s latest financial reports and current stock price. The company's current ROE is -144.27%. This represents a change of 318.82% compared to the average of -34.45% of the last 4 quarters.
The mean historical ROE of Abliva AB (publ) over the last ten years is -83.28%. The current -144.27% ROE has changed 73.23% with respect to the historical average. Over the past ten years (40 quarters), NEVPF's ROE was at its highest in in the December 2015 quarter at -4.83%. The ROE was at its lowest in in the March 2022 quarter at -111.94%.
Average
-83.28%
Median
-62.01%
Minimum
-297.45%
Maximum
0%
Discovering the peaks and valleys of Abliva AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 597.21%
Maximum Annual ROE = 0%
Minimum Annual Increase = -100.00%
Minimum Annual ROE = -297.45%
| Year | ROE | Change |
|---|---|---|
| 2024 | 0% | -100.00% |
| 2023 | -135.06% | 161.15% |
| 2022 | -51.72% | -82.61% |
| 2021 | -297.45% | 597.21% |
| 2020 | -42.66% | -29.08% |
| 2019 | -60.16% | -14.66% |
| 2018 | -70.49% | 6.39% |
| 2017 | -66.25% | 46.62% |
| 2016 | -45.19% | -29.24% |
| 2015 | -63.86% | 55.05% |
The current ROE of Abliva AB (publ) (NEVPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-62.26%
5-year avg
-105.38%
10-year avg
-83.28%
Abliva AB (publ)’s ROE is greater than Medivir AB (publ) (-37.65%), less than Relief Therapeutics Holding AG (0%), less than Oncopeptides AB (publ) (2.08%), greater than Small Pharma Inc. (-78.43%), less than Alpha Cognition Inc. (456.59%), less than IntelGenx Technologies Corp. (126.70%), greater than Herantis Pharma Oyj (-21354.84%), greater than ImmuPharma plc (-1397.44%), greater than Mindset Pharma Inc. (-316.17%), less than MedPeer,Inc. (4.47%),
| Company | ROE | Market cap |
|---|---|---|
| -37.65% | $45.78M | |
| 0% | $44.94M | |
| 2.08% | $55.98M | |
| -78.43% | $37.51M | |
| 456.59% | $35.66M | |
| 126.70% | $29.69M | |
| -21354.84% | $59.47M | |
| -1397.44% | $28.34M | |
| -316.17% | $54.51M | |
| 4.47% | $42.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abliva AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abliva AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Abliva AB (publ)'s ROE?
How is the ROE calculated for Abliva AB (publ) (NEVPF)?
What is the highest ROE for Abliva AB (publ) (NEVPF)?
What is the 3-year average ROE for Abliva AB (publ) (NEVPF)?
What is the 5-year average ROE for Abliva AB (publ) (NEVPF)?
How does the current ROE for Abliva AB (publ) (NEVPF) compare to its historical average?